Using technology to improve healthcare equity in type 1 diabetes
Using Technology to Address Disparities and Promote Healthcare Equity in Type 1 Diabetes Registry
This study is testing if using continuous glucose monitors and support from a Patient Navigator can help adolescents and adults with type 1 diabetes who have faced serious health challenges manage their condition better and improve their overall health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 14 Years to 64 Years |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06899984 on ClinicalTrials.gov |
What this trial studies
This study aims to address healthcare disparities in type 1 diabetes (T1D) by utilizing real-time continuous glucose monitoring systems (CGMS) alongside support from a Patient Navigator. Participants will include adolescents and adults with T1D who have experienced significant health challenges, such as multiple hospitalizations for diabetic ketoacidosis or high hemoglobin A1c levels. The study will collect data on health outcomes, healthcare experiences, and changes in diabetes management practices to evaluate the effectiveness of this approach in promoting better health equity. The goal is to provide tailored support and education to improve patient engagement and health outcomes.
Who should consider this trial
Good fit: Ideal candidates are males or females aged 14 to 64 years with a clinical diagnosis of type 1 diabetes and a history of significant health challenges related to their condition.
Not a fit: Patients who are unable or unwilling to share their CGMS data with the study team may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve health outcomes and quality of life for patients with type 1 diabetes by addressing disparities in care.
How similar studies have performed: Other studies have shown promise in using technology and patient navigation to improve health outcomes in chronic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males or females age 14 to 64 years * Clinical diagnosis of type 1 diabetes (T1D) * Two or more hospitalizations with diabetic ketoacidosis (DKA) within the past 5 years or hemoglobin A1c greater than 10% on two or more laboratory samples in the last 2 years. * Informed Consent * Has a CGMS or a prescription for a CGMS as part of their clinical care as part of their clinical care Exclusion Criteria: * Inability or unwillingness to share CGMS data with the study team
Where this trial is running
Chicago, Illinois
- University of Chicago — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Celeste Thomas, MD — University of Chicago
- Study coordinator: Celeste Thomas, MD
- Email: celeste.thomas@uchicagomedicine.org
- Phone: 773-702-6138
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.